Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-08 KANE MATTHEW R. President and CEO Sale −9,736 $9.00 $88K 1,941,246
2021-04-08 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 107,570
2021-03-18 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 3,990,909
2021-03-18 JANTZ DEREK Chief Scientific Officer Sale −9,665 $11.08 $107K 3,981,244
2021-03-18 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 129,084
2021-03-17 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 3,979,060
2021-03-17 JANTZ DEREK Chief Scientific Officer Sale −9,665 $10.92 $106K 3,969,395
2021-03-17 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 150,598
2021-03-16 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 3,967,207
2021-03-16 JANTZ DEREK Chief Scientific Officer Sale −9,661 $11.97 $116K 3,957,546
2021-03-16 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 172,112
2021-03-12 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,939,180
2021-03-12 KANE MATTHEW R. President and CEO Sale −9,712 $11.36 $110K 1,929,468
2021-03-12 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 129,084
2021-03-11 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,927,377
2021-03-11 KANE MATTHEW R. President and CEO Sale −9,711 $11.38 $111K 1,917,666
2021-03-11 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 150,598
2021-03-10 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,915,573
2021-03-10 KANE MATTHEW R. President and CEO Sale −9,710 $11.79 $114K 1,905,863
2021-03-10 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 172,112

Page 22 of 23 · 456 trades